Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ivan Iurchenko has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Triazin-5-ones Derivatives as Potential Antiseizure Medicines

    by Anatolii Demchenko, Artur Martynov, Volodymyr Zaitsev, Yevhenii Novodvorskyi, Oleh Yadlovskyi, Albina Mikhraliieva, Yulia Fedchenkova, Tatyana Bomko, Tatyana Nosalsky, Sergii Demchenko, et al.

    Introduction: Epilepsy is a major global health burden, affecting more than 70 million people worldwide. Approximately 20-30% of patients do not achieve adequate seizure control with currently available antiseizure medications. This study investigates novel triazin-5-one derivatives as potential antiseizure agents targeting the γ-aminobutyric acid (GABA) system. The compounds were designed to interact with GABAA receptors and inhibit GABA aminotransferase (GABA-AT), using lamotrigine as a reference antiseizure drug. This dual-target strategy may support the development of more effective therapies for drug-resistant epilepsy. Materials and Methods: Eighteen 6-(4-methoxybenzyl)-3-R-4H-[1,2,4]triazin-5-one derivatives (3a–r) were synthesized and characterized by 1H and 13C NMR spectroscopy, LC-MS, and elemental analysis. Molecular docking was performed against the GABAA receptor (PDB ID: 1OHV) and GABA-AT enzyme (PDB ID: 1SF2) to estimate binding affinity. GABA-AT inhibition was evaluated in vitro, and anticonvulsant activity was assessed in mouse models at doses equimolar to 10 mg/kg lamotrigine. Results: Compounds 3o, 3f, 3r, 3g, and 3h showed the highest predicted binding affinities for the GABAA receptor, with binding-energy magnitudes exceeding 10 kcal/mol. Compound 3h (3-(2,3-dimethylphenylamino)-6-(4-methoxybenzyl)-4H-[1,2,4]triazin-5-one) exhibited the lowest IC50 value for GABA-AT inhibition (30.50 ± 0.61 μM), comparable to that of lamotrigine (32.7 ± 0.7 μM). In the animal model, compounds 3f and 3h completely suppressed clonic and recurrent clonic-tonic seizures. Docking analysis indicated that 3h forms hydrogen bonds with Arg430 and Ile426 through the triazine oxygen atom and interacts with His44 through a triazine nitrogen atom. Discussion: The anticonvulsant effects of these 1,2,4-triazine derivatives appear to depend on the substituents at positions 3 and 6 of the heterocyclic ring. Their potential dual mechanism, involving both receptor modulation and enzyme inhibition, may contribute to their neurotropic activity. Compound 3r contains a defined pharmacophore incorporating tryptamine and triazine fragments, whereas the spatial requirements underlying the activity of compound 3h remain unclear and require further structural investigation. Conclusion: The study identifies novel triazin-5-ones, specifically compounds 3h and 3f, as promising candidates for the development of new antiseizure therapies. These derivatives demonstrate potency and efficacy comparable to lamotrigine and may offer a multi-target mechanism within the GABAergic system.

  • Design, synthesis, and in vitro anticancer and anti-influenza evaluation of 2-amino-3-benzoyl-N-indolizine-1-carboxamide derivatives

    by Anatolii Demchenko, Ivan Iurchenko, Volodymyr Zaitsev, Yevhenii Novodvorskyi, Volodymyr Sukhovieiev, Lida Zavodovska, Sergii Demchenko, Sergii Tarnavsky, Sergii Yarmoluk

  • Open Access

    Novel triazin-5-ones as potential antiseizure medicines

    by Artur Martynov, Anatolii Demchenko, Volodymyr Zaitsev, Yevhenii Novodvorskyi, Oleh Yadlovskyi, Albina Mikhraliieva, Yuliia Fedchenkova, Tatyana Bomko, Tatyana Nosalska, Sergii Demchenko, et al.

    Novel triazin-5-ones as potential antiseizure medicines Anxiety and related issues are major health and social concerns in developed countries, affecting 10–20% of the population. The lowest effective inhibitory concentrations for GABA-AT were observed for two compounds: 3h (30.50±0.61 µM) and 3r (44.76±0.49 µM). Their IC50 values were similar to those of lamotrigine. In vitro tests showed that compounds 3h and 3f had the lowest IC50 values for GABA-AT inhibition, at 30.50±0.61 and 44.58±0.54, respectively. The anticonvulsant activity of 6-(4-methoxybenzyl)-3-R-4H-[1,2,4] triazin-5-ones in a corral seizure model depends on modifications to substituents at positions three and six of the heterocyclic 1,2,4-triazine ring. Leading compounds, 3f (3-(4-Chlorophenylamino)-6-(4-methoxybenzyl)-4H-[1,2,4]triazin-5-one) and 3h (3-(2,3-Dimethylphenylamino)-6-(4-methoxybenzyl)-4H-[1,2,4]triazin-5-one), completely inhibit clonic and tonic-clonic seizures. Compound 3r, which contains both tryptamine and triazine fragments, has a clear pharmacophore structure. However, the spatial structure of the pharmacophore in compound 3h, with the lowest binding energy to GABAa and GABA-AT and the best performance in tests, is not yet fully understood.

  • Open Access

    Modeling of New Agents with Potential Antidiabetic Activity Based on Machine Learning Algorithms

    by Yevhen Pruhlo, Ivan Iurchenko, Alina Tomenko

    Type 2 diabetes mellitus (T2DM) is a growing global health challenge, expected to affect over 600 million people by 2045. The discovery of new antidiabetic agents remains resource-intensive, motivating the use of machine learning (ML) for virtual screening based on molecular structure. In this study, we developed a predictive pipeline integrating two distinct descriptor types: high-dimensional numerical features from the Mordred library (>1800 2D/3D descriptors) and categorical ontological annotations from the ClassyFire and ChEBI systems. These encode hierarchical chemical classifications and functional group labels. The dataset included 45 active compounds and thousands of inactive molecules, depending on the descriptor system. To address class imbalance, we applied SMOTE and created balanced training and test sets while preserving independent validation sets. Thirteen ML models—including regression, SVM, naive Bayes, decision trees, ensemble methods, and others—were trained using stratified 12-fold cross-validation and evaluated across training, test, and validation. Ridge Regression showed the best generalization (MCC = 0.814), with Gradient Boosting following (MCC = 0.570). Feature importance analysis highlighted the complementary nature of the descriptors: Ridge Regression emphasized ClassyFire taxonomies such as CHEMONTID:0000229 and CHEBI:35622, while Mordred-based models (e.g., Random Forest) prioritized structural and electronic features like MAXsssCH and ETA_dEpsilon_D. This study is the first to systematically integrate and compare structural and ontological descriptors for antidiabetic compound prediction. The framework offers a scalable and interpretable approach to virtual screening and can be extended to other therapeutic domains to accelerate early-stage drug discovery.

  • Open Access

    Determination of Mequitazine in Tablets by Difference Spectrophotometry Based on the Absorption of its Sulfoxide

    by Mykola Blazheyevskiy, Ivan Iurchenko

    A new method is described for the rapid determination of (R)-(+)-Mequitazine. The drug is determined by a difference spectrophotometric technique based upon the absorbance of its sulphoxide derivative relative to the absorbance of a solution of the underivatized drug. The sulphoxide derivative are formed rapidly and quantitatively at room temperature by the addition of a solution of potassium caroate in form Oxone. The difference absorbance of the solutions is proportional to the concentration of the Mequitazine in the preparation and is specific for the intact drug in the presence of oxidative and photochemical decomposition products and excipients. Linearity range 1.00–35.00 µg/mL. The regression line equation is ΔA (342 nm) =0.05×C (r=0.99) where C is in µg/ml Mequitazine. The limit of quantitation, LOQ (10S), is 1.0 µg/mL. The possibility of quantitative determination of Mequitazin in Primalan 10 mg tablets has been demonstrated. RSD ≤ 1.5%; ((– µ) 100%/µ =+0.80%). ‘µ’ is data of quantitative determination by the reference pharmacopoeial method.


  • Titrimetric determination of Hydroxyzine using Oxone

    by Ivan Iurchenko, Mykola Blazheyevskiy, Vitaliy Yaremenko, Valeriy Moroz, Oleg Kryskiv


  • Open Access

    Titrimetric micro determination of hydroxyzine using Oxone

    by Ivan Iurchenko, Mykola Blazheyevskiy, Vitaliy Yaremenko, Valeriy Moroz, Oleg Kryskiv

    The kinetics of the oxidation reaction of hydroxyzine hydrochloride with potassium hydrogen peroxomonosulfate was studied depending on the pH of the medium. It was established for the first time that the kinetics of the reaction of N-oxidation of hydroxyzine obeyed the general laws of the mechanism of specific acid-base catalysis, proceeded quantitatively and stoichiometrically according to the mechanism of nucleophilic substitution of the β-oxygen atom of the peroxyacid group of peroxomonosulfate ions. It was shown that quantitative oxidation was achieved in 1–1.5 minutes at pH 8.0–8.5. The only reaction product was hydroxyzine N-oxide. A scheme of the oxidation process was proposed. Techniques were developed and the possibility of quantitative determination of hydroxyzine hydrochloride in the substance and tablets of 25 mg by iodometry using Oxone as an analytical reagent was shown. A known excess of reagent was added, and after a predetermined time, the residual reagent was determined iodometrically. RSD ≤ 1.52%. (x̅ - µ)· 100 / µ < RSD. The procedures had several advantages such as speed, simplicity, accuracy, selectivity, and cost-effectiveness, and therefore could be easily adapted by quality control laboratories for routine analysis.